Financials data is unavailable for this security.
View more
Year on year Shanghai Runda Medical Technology Co Ltd 's revenues fell -12.84% from 10.49bn to 9.15bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 417.75m to 273.30m, a -34.58% decrease.
| Gross margin | 25.94% |
|---|---|
| Net profit margin | 2.03% |
| Operating margin | 4.27% |
| Return on assets | 1.18% |
|---|---|
| Return on equity | 0.96% |
| Return on investment | 3.13% |
More ▼
Cash flow in CNYView more
In 2023, Shanghai Runda Medical Technology Co Ltd increased its cash reserves by 38.66%, or 171.00m. The company earned 729.72m from its operations for a Cash Flow Margin of 7.98%. In addition the company used 227.34m on investing activities and also paid 331.32m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.17 |
|---|---|
| Tangible book value per share | 3.66 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.19 |
|---|---|
| Quick ratio | 1.01 |
| Total debt/total equity | 1.64 |
|---|---|
| Total debt/total capital | 0.5609 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -33.33% and -32.86%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.56% |
|---|---|
| Div growth rate (5 year) | 1.03% |
| Payout ratio (TTM) | 148.31% |
| EPS growth(5 years) | 0.7836 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -89.93 |
More ▼
